Calcium hydroxycitrate in its turn is a potential inhibitor of ATP citrate lyase (ACL) and thus is expected to decrease fluxes to lipid production, thus limiting a crucial anabolic pathway for highly proliferative tumor cells. This evidence concerns the gene ACLY and neoplasm.